Where Capital Meets
Strategic Conviction
Innekto Incorporated is an investment and advisory firm operating across commodities trading, investment banking, and strategic consulting for institutional counterparties across 30+ markets.
Four Integrated Practice Areas
Precious Metals & Commodity Trading
Trading and investment across gold, silver, essential oils, and agricultural commodities. Structured yield strategies with risk-managed commodity exposure for qualified counterparties.
Private Markets Investment Banking
Full-spectrum investment banking services for private market transactions. M&A advisory, capital raising, structured financing, and strategic advisory — exclusively in private markets.
Healthcare & Regulatory Advisory
Deep-domain consulting across healthcare systems, wellness, medical devices, and regulatory pathways. From FDA 510(k) strategy to MENA market entry, we provide execution-ready advisory.
First-Time Fund Manager Advisory
Comprehensive advisory for emerging VC and PE fund managers navigating fund formation, LP strategy, governance design, and operational build-out for their inaugural vehicle.
Risk-Managed Exposure
to Premium Commodities
Innekto Incorporated offers institutional counterparties structured access to carefully selected commodity categories with demonstrated supply scarcity and yield potential. Our trading operations are underpinned by rigorous risk management, certified supply chains, and transparent execution.
All commodity strategies are subject to market conditions, counterparty qualification, and applicable regulatory requirements. Target returns are indicative projections only and are not guaranteed.
Explore Commodities| Commodity | Price | Unit | Change |
|---|---|---|---|
Precious metals prices are indicative and sourced from market data feeds. Data may be delayed up to 15 minutes and may not reflect current trading prices. Not an offer to buy or sell. Reference pricing only. Prices reflect current market reference levels and are subject to grade, origin, lot characteristics, and supplier availability. Prices are updated periodically and may not reflect real-time market conditions. Not an offer to buy or sell.
Private Market Transactions.
Institutional Execution.
View Banking PracticeExclusive financial advisor to a women's health pharmaceutical business on its divestiture to a strategic acquirer. Managed the full sell-side process from positioning through close.
Financial advisor to a specialty pharmaceutical company in a landmark $28 billion acquisition, one of the largest pharma transactions of the year. Provided strategic counsel across valuation, negotiation, and transaction execution.
Exclusive financial advisor to a radiosurgery company in its $277 million acquisition of a radiation therapy platform, expanding its oncology technology portfolio.
Financial advisor to a contract research organisation (CRO) on its sale to a strategic buyer. Supported the full divestiture process including buyer outreach, due diligence coordination, and definitive agreement.
Healthcare & Regulatory Expertise
Systems transformation, operational efficiency, and capital raise support for private healthcare groups.
View →WellnessRegulatory strategy and market positioning for consumer wellness and nutraceutical companies across multiple jurisdictions.
View →Medical DevicesEnd-to-end regulatory strategy, 510(k) and PMA preparation, and commercialisation advisory for device manufacturers.
View →RegulatoryFDA, EU MDR, and GCC regulatory pathway design. From pre-submission meetings to market authorisation.
View →Institutional Support for
First-Time Fund Managers
Innekto Incorporated provides comprehensive end-to-end advisory to first-time VC and PE fund managers. From fund formation and GP/LP economics design through to fundraising strategy, compliance, and operational infrastructure — we help emerging managers establish a credible institutional foundation.
Emerging Manager ServicesMarket Intelligence
Gold's Structural Bid: Why Central Bank Accumulation Is Reshaping the Market
Central bank demand exceeded 1,000 tonnes for a second consecutive year, fundamentally altering supply-demand dynamics in the gold market an…
FDA's 2025 Digital Health Policy Update: Implications for Class II Device Sponsors
The FDA's updated guidance on AI/ML-enabled medical devices introduces a predetermination change control plan framework that meaningfully af…
Private Credit's Expansion into Middle East M&A: Structural Shift or Cyclical Rotation?
Institutional private credit funds are increasingly participating as acquisition financing vehicles in GCC M&A transactions, displacing trad…
Engage With Our Team
Innekto Incorporated works exclusively with institutional counterparties, qualified professional investors, and corporate clients. To discuss your requirements, request a consultation with a member of our team.
Request ConsultationThe information presented on this page is intended for institutional counterparties and professional investors only. All references to target returns, yield strategies, and projected outcomes represent forward-looking estimates subject to material market, credit, liquidity, and operational risks. Past performance is not indicative of future results. Nothing herein constitutes an offer to buy or sell securities or investment products.